Home/Filings/4/0001415889-24-008260
4//SEC Filing

Lettmann Jason 4

Accession 0001415889-24-008260

CIK 0001810182other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:06 PM ET

Size

4.6 KB

Accession

0001415889-24-008260

Insider Transaction Report

Form 4
Period: 2024-03-14
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Purchase

    Common Stock

    2024-03-14$11.31/sh+4,400$49,771171,620 total

Issuer

ALX ONCOLOGY HOLDINGS INC

CIK 0001810182

Entity typeother

Related Parties

1
  • filerCIK 0001688269

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:06 PM ET
Size
4.6 KB